These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1838766)

  • 21. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats.
    Adams MA; Bobik A; Korner PI
    Hypertension; 1990 Sep; 16(3):252-60. PubMed ID: 2394485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF; Devlin AM; Lee WK; Anderson NH; Bohr DF; Reid JL
    Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of left ventricular and coronary vascular hypertrophy on cardiac performance.
    Friberg P; Nordlander M
    J Hypertens; 1990 Oct; 8(10):879-89. PubMed ID: 2174939
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF; de Azevedo Carvalho AC; Pimentel EB; Mill JG; Nascimento JH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic advances in the treatment of left ventricular hypertrophy.
    Natsume T
    Eur Heart J; 1993 Jul; 14 Suppl D():33-7. PubMed ID: 8370375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different left ventricular remodelling and function in two models of pressure overload as assessed in vivo by magnetic resonance imaging.
    Laurent D; Allergrini PR; Zierhut W
    J Hypertens; 1995 Jun; 13(6):693-700. PubMed ID: 7594428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
    Brilla CG; Janicki JS; Weber KT
    Circulation; 1991 May; 83(5):1771-9. PubMed ID: 1850668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease.
    Strauer BE
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S45-54. PubMed ID: 2468873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of cardiac, but not vascular, hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke-prone rats.
    Head GA; Minami N
    Am J Med; 1992 Apr; 92(4B):54S-59S. PubMed ID: 1533747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the renin-angiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats.
    Dang A; Zheng D; Wang B; Zhang Y; Zhang P; Xu M; Liu G; Liu L
    Hypertens Res; 1999 Sep; 22(3):217-21. PubMed ID: 10515445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia.
    Amrani FC; Cheaw SL; Chevalier B; Paolaggi F; Jouquey S; Hamon G; Swynghedauw B
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):155-65. PubMed ID: 7511729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathoadrenal system is critical for structural changes in genetic hypertension.
    Korner P; Bobik A; Oddie C; Friberg P
    Hypertension; 1993 Aug; 22(2):243-52. PubMed ID: 8340160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.
    Mueller SM; Cohen ML
    Artery; 1985; 12(6):337-45. PubMed ID: 2996465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats.
    Mitchell GF; Pfeffer MA; Finn PV; Pfeffer JM
    Circulation; 1996 Dec; 94(11):2923-9. PubMed ID: 8941122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and function of the arteries in hypertension.
    Folkow B
    Am Heart J; 1987 Oct; 114(4 Pt 2):938-48. PubMed ID: 3661386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.